Moleculin Biotech, Inc. (MBRX) Social Stream



Moleculin Biotech, Inc. (MBRX): $1.50

0.03 (+2.35%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add MBRX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 454

in industry

Moleculin Biotech Inc (MBRX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Moleculin Biotech Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-18 3 $29 $10 $19 $1.77 973.45%
2022-03-25 3 $29 $10 $18 $1.77 916.95%

The Trend in the Analyst Price Target


Over the past 32 weeks, MBRX's average price target has gone down $2.33.

Over the past 51 weeks, MBRX's average upside potential has been 552.98%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-25 1 29 14 20.33 3.50 480.86%
2021-05-08 1 29 14 20.33 3.35 506.87%
2021-06-26 1 29 14 20.33 3.92 418.62%
2021-07-10 1 29 14 20.33 3.56 471.07%
2021-08-01 1 29 14 20.33 3.12 551.6%

MBRX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


Over the past 21 months, MBRX's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, Moleculin Biotech Inc's upside potential (average analyst target price relative to current price) is higher than 197.84% of them.
  • To contextualize these metrics, consider that out of all US stocks, Moleculin Biotech Inc's variance in analysts' estimates is lower than -85.51% of them.
  • Moleculin Biotech Inc's number of analysts covering the stock is greater than 25.2% of Healthcare stocks.
  • In terms of how Moleculin Biotech Inc fares relative to stocks in the micro market cap category, note that its average analyst price target is greater than 144.72% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Moleculin Biotech Inc are LTRN, LPTX, and LBPH.

Make investment decisions regarding MBRX using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5089 seconds.